The Firm - Our Team

Engel & Novitt, LLP is an internationally-recognized boutique law firm with a global biopharmaceuticals and medical device client base spanning Europe, the United States, and the Pacific Rim. Recognized as leaders in legal/regulatory and compliance issue impacting FDA-regulated industries, Engel & Novitt develops and implements innovative and forward-thinking science-based solutions to anticipate and resolve complex scientific, science policy, legal/regulatory, legislative, life-cycle management, public policy, and business issues affecting innovative industries in the firm's core practice areas relating to drugs, biologics, medical devices, and genomics. [More]

The Engel & Novitt management and leadership team is led by its founding partners, John Engel and Anita Novitt, along with the exceptional scientific expertise of the firm's Chief Scientist, Dr. Gillian Woollett. Together with the other members of the unique Engel & Novitt multi-disciplinary Team, the firm brings over seven decades of experience working with cutting-edge biopharmaceuticals, device, and clinical research and drug development industries in a variety of capacities. [More]

2401 Pennsylvania Avenue, N.W., Suite 310
Washington, D.C. 20037
Telephone +1.202.207.3300 - Facsimile +1.202.207.3318 - email: < engelnovitt AT engelnovitt.com >